FDA Inspection 1018289 — Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. on June 21, 2017 in Fengxian District. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- June 21, 2017
- Fiscal Year
- 2017
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Fengxian District (China)